ASP Isotopes Inc. (NASDAQ: ASPI) has disclosed a comprehensive plan to merge its wholly‑owned subsidiary, Noble Africa LLC, with a subsidiary of ENDRA Life Sciences Inc. (NASDAQ: NDRA). The combined entity will be renamed Noble Africa Inc. and will seek a listing on the Nasdaq Stock Market under the ticker symbol “NOBA.” In parallel with the merger, the companies have arranged a concurrent private‑placement financing expected to generate roughly $50 million in gross proceeds. Of this amount, ASP Isotopes will contribute about $20 million as the lead investor, while other accredited investors, qualified institutional buyers, and non‑U.S. persons will provide the remaining $30 million, including a $750,000 commitment from certain ASP Isotopes directors and management.
The strategic purpose of these transactions is to create a dedicated, publicly‑traded platform for Renergen’s Virginia Gas Project, a helium‑focused development located in South Africa’s Free State Province. Helium, a noble gas with critical applications in semiconductor manufacturing, medical imaging (including MRI), aerospace, and scientific research, has experienced tightening global supply in recent years. By establishing a Nasdaq‑listed vehicle, the parties aim to give investors direct exposure to one of the few publicly traded helium development assets worldwide, thereby supporting the project’s Phase 1 and Phase 2 development while preserving meaningful exposure for ASP Isotopes shareholders.
The merger and financing are subject to customary regulatory approvals, including the effectiveness of a Form S‑4 registration statement with the U.S. Securities and Exchange Commission (SEC), approval by ENDRA’s stockholders, and satisfaction of other closing conditions. The parties anticipate that the transactions will close in the third or fourth quarter of 2026.
Merger Structure and Ownership
Under the definitive merger agreement, Noble Africa LLC will survive as the surviving entity, and the combined company will be renamed Noble Africa Inc. Upon closing, ASP Isotopes is expected to own approximately 89 % of the combined company. Pre‑closing ENDRA shareholders are projected to hold about 3 %, while investors participating in the private‑placement financing (excluding ASP Isotopes) will own roughly 7 %.
The transaction has received board approvals from both ASP Isotopes and ENDRA. Closing is contingent upon several regulatory milestones: the filing and effectiveness of a registration statement on Form S‑4 with the SEC, approval of the merger by ENDRA’s stockholders, and the satisfaction of customary closing conditions. The parties have indicated that the closing is targeted for the third or fourth quarter of 2026.
Leadership of the combined company will be anchored by Paul E. Mann, who serves as CEO of Renergen and as CEO/Executive Chairman of ASP Isotopes, and will assume the role of chief executive of Noble Africa Inc. Nick Mitchell, COO of Renergen and Co‑COO of ASP Isotopes, will serve as chief operating officer. The board will consist of six directors: four appointed by ASP Isotopes (including the CEO), one designated by ENDRA, and one non‑executive director selected by the combined company’s CEO.
Strategic Rationale for the Energy Sector
The merger creates a dedicated, publicly traded platform for the Virginia Gas Project, which holds a 94.5 % equity interest in Tetra4 Proprietary Limited, the operator of an on‑shore natural‑gas and helium production facility. Helium’s unique physical properties make it indispensable for a range of high‑technology and life‑science applications, and global supply constraints have heightened the strategic importance of secure, reliable sources.
ENDRA’s CEO, Alex Tokman, described the Virginia Gas Project as a “well‑positioned opportunity in a dynamic industry,” emphasizing the project’s potential to address tightening helium supply. ASP Isotopes CEO Paul Mann echoed this sentiment, noting that the merger and concurrent financing will provide Noble Africa with the capital structure, public‑market access, and funding needed to advance Phase 1 and Phase 2 development while allowing ASP Isotopes shareholders to retain “meaningful exposure to the long‑term opportunity.”
By listing on Nasdaq, Noble Africa aims to broaden the investor base and deliver transparent, market‑driven pricing for a helium development asset that is otherwise difficult for retail and institutional investors to access. This aligns with broader industry trends where companies are seeking public‑market vehicles to fund capital‑intensive resource projects, especially those involving critical materials such as helium.
Financing, Advisors, and Transaction Timing
The private placement will close immediately prior to the merger’s consummation. Commitments have been secured from a mix of accredited investors, qualified institutional buyers, and non‑U.S. persons. In addition to the $20 million lead investment from ASP Isotopes, the placement includes a $750,000 contribution from certain ASP Isotopes directors and management, underscoring internal confidence in the transaction.
Placement agents:
- Lucid Capital Markets – handling U.S. investors
- OceanWall – handling ex‑U.S. investors
Legal counsel:
- ENDRA – K&L Gates LLP
- ASP Isotopes – Haynes and Boone, LLP
Financial advisor: Lucid Capital Markets is serving as financial advisor to ENDRA. Ellenoff Grossman & Schole LLP is providing legal counsel to the placement agents.
The parties plan to file a registration statement on Form S‑4 with the SEC to register the securities issued in connection with the merger. The effectiveness of this filing, along with ENDRA stockholder approval and the satisfaction of customary closing conditions, will trigger the final closing of both the merger and the private placement.
Key Takeaways
- ASP Isotopes’ subsidiary Noble Africa will merge with an ENDRA subsidiary, creating Noble Africa Inc., which plans to list on Nasdaq under the ticker “NOBA.”
- The concurrent private placement is expected to generate approximately $50 million in gross proceeds, including $20 million from ASP Isotopes and $30 million from other investors.
- Post‑closing ownership is projected at 89 % ASP Isotopes, 3 % ENDRA shareholders, and 7 % private‑placement investors, with the transaction slated to close in Q3‑Q4 2026.
EnergyInsyte's Take
The proposed merger gives the Virginia Gas Project a clear path to public‑market financing, potentially easing capital constraints for helium production—a material increasingly vital to high‑tech and medical sectors. Execution risk remains, as the closing depends on SEC registration, ENDRA shareholder consent, and other standard conditions. Energy executives should monitor the merger’s progress, the timing of the Nasdaq listing, and any subsequent capital calls that could affect the project’s development schedule.
Source: Businesswire
